Eli Lilly And Company - Company Profile

Access all 5,000+ company profiles through the Benchmarking Pro Membership. Unlock interactive competitor comparison tools that show you how Eli Lilly And Company stacks up to the competition and put relevant competitor and industry information at your fingertips.

Eli Lilly And Company - Overview

Brands

Alimta, Byetta, Cialis, Cymbalta, Darvocet, E-Mycin, Effient, Evista, Forteo, Gemzar, Glucagon, Humatrope, Humulin, Methadone, Prozac, ReoPro, Secobarbital, Strattera, Xigris, Zyprexa

Description

Eli Lilly And Company is a public company headquartered in Indiana with an estimated 45,150 employees. In the US, the company has a notable market share in at least two industries: Brand Name Pharmaceutical Manufacturing, Insulin Manufacturing and Brand Name Pharmaceutical Manufacturing. Their largest market share is in the Insulin Manufacturing industry, where they account for an estimated 40.6% of total industry revenue.

Company Details

Registered Name: Eli Lilly And Company
Company Type: Operating
Exchange: NYSE
Headquarters: 893 Delaware St, Indianapolis, IN 46225
Website: http://www.lilly.com/
Employees: 45,150

Eli Lilly And Company - Operating Industries and Main Competitors

OD5310 - Insulin Manufacturing
- Eli Lilly And Company Market Share: x.x%
- Sanofi Market Share: x.x%
- Novo Nordisk A Market Share: x.x%
32541a - Brand Name Pharmaceutical Manufacturing
- Eli Lilly And Company Market Share: x.x%
- Ucb S.A. Market Share: x.x%
- Abbvie inc. Market Share: x.x%
- Pfizer Inc. Market Share: x.x%
- Bristol-Myers Squibb Sa Market Share: x.x%

To view all of Eli Lilly And Company's operating industries and competitors, see purchase options.

Eli Lilly And Company - Products and Services

Insulin Manufacturing

Of the 2 core revenue-generating products and services in the Insulin Manufacturing industry, Eli Lilly And Company offers:

Long-acting insulin
Premix insulin

Brand Name Pharmaceutical Manufacturing

Of the 8 core revenue-generating products and services in the Brand Name Pharmaceutical Manufacturing industry, Eli Lilly And Company offers:

Cardiovascular prescriptions
Diabetes prescriptions
Mental health and nervous system prescriptions
Oncology prescriptions
Other prescriptions

To view Eli Lilly And Company's full products and services, see purchase options.

Eli Lilly And Company - SWOT Analysis

Strengths and weaknesses take into account internal factors, and are based on Eli Lilly And Company's performance in comparison to its competitors. Opportunities and Threats focus on external influences, and are based on trends and demand in the Insulin Manufacturing , Brand Name Pharmaceutical Manufacturing industries

Strengths

Days Receivables: x.x%

Rank: 2 of 3 peers

Annual Turnover: x.x%

Rank: 2 of 3 peers

Weaknesses

Credit Risk: x.x%

Rank: 2 of 3 peers

Revenue per Employee: $xx

Rank: 2 of 3 peers

Opportunities

Threats

AAAAA
AAAAA
AAAAA

To view Eli Lilly And Company's full SWOT analysis, see purchase options.

Looking for IBISWorld Industry Reports?

Gain strategic insight and analysis on 700+ in the United States industries
(& thousands of global industries)

Browse industries

Eli Lilly And Company - Financial Statements

Eli Lilly And Company Income Statement

BALANCE DATE	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023
Revenue	21,493.3	22,319.5	24,539.8	28,318.4	28,541.4	34,124.1
Cost of Revenue
Cost of Revenue, Non-Cash
Gross Profit
00000

Eli Lilly And Company Balance Sheet

BALANCE DATE	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023
Cash and Equivalents	7,320.7	2,337.5	3,657.1	3,818.5	2,067.0	2,818.6
Short-Term Investments
Derivative Assets, Current
Restricted Cash and Investments
00000

Eli Lilly And Company Cash Flow

BALANCE DATE	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023
Net Income	N/A	N/A	N/A	N/A	N/A	N/A
Income (Loss) From Discontinued Operations
Depreciation, Depletion and Amortization
Amortization of Financing Costs and Discounts
00000

To view all financial data for Eli Lilly And Company, see purchase options.

Why purchase access to Benchmarking Pro?

This profile on Eli Lilly And Company includes:

Company Overview
Company Revenue and Employee Data
Company Financial Statements
Industry Market Share Breakdown
Industry Competitor Matrix
SWOT Analysis
Products and Services
Key Company Benchmarks
Interconnected Competitor Profiles and Industry Reports
Full Access to Benchmarking Pro

The IBISWorld Benchmarking Pro solution enables you to:

Understand an enterprise’s competitive landscape and how they perform within a like-sized industry segment.
Benchmark companies against industry averages, segment averages and their competitors.
Identify real-world strengths, opportunities, weaknesses and threats for companies.
Target growth opportunities or spot red flags in a business growth strategy.
Toggle between company profiles and industry reports for a 360 degree view of a company's position.

IBISWorld provides profiles on thousands of leading companies around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends across all sectors of the economy. This company profile, along with the corresponding competitor and industry data provided, includes thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

Get Instant Access with Benchmarking Pro Membership

Purchase options Download Sample

Benchmarking Pro

What's Inside
Benchmarking Pro?

A suite of company and industry data that:

Benchmarks companies against industry averages or like-sized segments, as well as close competitors
Identifies real-world strengths, opportunites, weaknesses and threats
Reveals growth opportunities or red flags in a business growth strategy

Learn more